Clinical Trial Details
| Trial ID: | L2964 |
| Source ID: | NCT06695572 |
| Associated Drug: | Ckd-383 |
| Title: | Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy Volunteers |
| Acronym: | CKD-383 FDI P1 |
| Status: | RECRUITING |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes Mellitus (T2DM) |
| Interventions: | DRUG: CKD-383 |
| Outcome Measures: | Primary: AUCt of CKD-383, Area under the CKD-383 concentration in blood-time curve from 0 to t, 0, 0.25, 0.5, 0.75, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 7, 8, 10, 12, 24, 48 hours|Cmax of CKD-383, The maximum CKD-383 concentration in blood sampling time t, 0, 0.25, 0.5, 0.75, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 7, 8, 10, 12, 24, 48 hours | |
| Sponsor/Collaborators: | Sponsor: Chong Kun Dang Pharmaceutical | Collaborators: Bumin Hospital |
| Gender: | ALL |
| Age: | ADULT |
| Phases: | PHASE1 |
| Enrollment: | 30 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2024-11-06 |
| Completion Date: | 2024-12-16 |
| Results First Posted: | |
| Last Update Posted: | 2024-11-19 |
| Locations: | Bumin Hospital, Gangseo-gu, Seoul, 07590, Korea, Republic of |
| URL: | https://clinicaltrials.gov/show/NCT06695572 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|